IBDEI11L ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16941,0)
 ;;=K76.0^^61^778^12
 ;;^UTILITY(U,$J,358.3,16941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16941,1,3,0)
 ;;=3^Fatty Liver NEC
 ;;^UTILITY(U,$J,358.3,16941,1,4,0)
 ;;=4^K76.0
 ;;^UTILITY(U,$J,358.3,16941,2)
 ;;=^5008831
 ;;^UTILITY(U,$J,358.3,16942,0)
 ;;=K76.89^^61^778^20
 ;;^UTILITY(U,$J,358.3,16942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16942,1,3,0)
 ;;=3^Liver Disease NEC
 ;;^UTILITY(U,$J,358.3,16942,1,4,0)
 ;;=4^K76.89
 ;;^UTILITY(U,$J,358.3,16942,2)
 ;;=^5008835
 ;;^UTILITY(U,$J,358.3,16943,0)
 ;;=K71.6^^61^778^34
 ;;^UTILITY(U,$J,358.3,16943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16943,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,16943,1,4,0)
 ;;=4^K71.6
 ;;^UTILITY(U,$J,358.3,16943,2)
 ;;=^5008801
 ;;^UTILITY(U,$J,358.3,16944,0)
 ;;=K75.9^^61^778^19
 ;;^UTILITY(U,$J,358.3,16944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16944,1,3,0)
 ;;=3^Inflammatory Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16944,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,16944,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,16945,0)
 ;;=K71.0^^61^778^26
 ;;^UTILITY(U,$J,358.3,16945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16945,1,3,0)
 ;;=3^Toxic Liver Disease w/ Cholestasis
 ;;^UTILITY(U,$J,358.3,16945,1,4,0)
 ;;=4^K71.0
 ;;^UTILITY(U,$J,358.3,16945,2)
 ;;=^5008793
 ;;^UTILITY(U,$J,358.3,16946,0)
 ;;=K71.10^^61^778^32
 ;;^UTILITY(U,$J,358.3,16946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16946,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
 ;;^UTILITY(U,$J,358.3,16946,1,4,0)
 ;;=4^K71.10
 ;;^UTILITY(U,$J,358.3,16946,2)
 ;;=^5008794
 ;;^UTILITY(U,$J,358.3,16947,0)
 ;;=K71.11^^61^778^33
 ;;^UTILITY(U,$J,358.3,16947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16947,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
 ;;^UTILITY(U,$J,358.3,16947,1,4,0)
 ;;=4^K71.11
 ;;^UTILITY(U,$J,358.3,16947,2)
 ;;=^5008795
 ;;^UTILITY(U,$J,358.3,16948,0)
 ;;=K71.2^^61^778^25
 ;;^UTILITY(U,$J,358.3,16948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16948,1,3,0)
 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
 ;;^UTILITY(U,$J,358.3,16948,1,4,0)
 ;;=4^K71.2
 ;;^UTILITY(U,$J,358.3,16948,2)
 ;;=^5008796
 ;;^UTILITY(U,$J,358.3,16949,0)
 ;;=K71.3^^61^778^30
 ;;^UTILITY(U,$J,358.3,16949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16949,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
 ;;^UTILITY(U,$J,358.3,16949,1,4,0)
 ;;=4^K71.3
 ;;^UTILITY(U,$J,358.3,16949,2)
 ;;=^5008797
 ;;^UTILITY(U,$J,358.3,16950,0)
 ;;=K71.4^^61^778^29
 ;;^UTILITY(U,$J,358.3,16950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16950,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
 ;;^UTILITY(U,$J,358.3,16950,1,4,0)
 ;;=4^K71.4
 ;;^UTILITY(U,$J,358.3,16950,2)
 ;;=^5008798
 ;;^UTILITY(U,$J,358.3,16951,0)
 ;;=K75.81^^61^778^21
 ;;^UTILITY(U,$J,358.3,16951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16951,1,3,0)
 ;;=3^Nonalcoholic Steatohepatitis (NASH)
 ;;^UTILITY(U,$J,358.3,16951,1,4,0)
 ;;=4^K75.81
 ;;^UTILITY(U,$J,358.3,16951,2)
 ;;=^5008828
 ;;^UTILITY(U,$J,358.3,16952,0)
 ;;=K75.89^^61^778^18
 ;;^UTILITY(U,$J,358.3,16952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16952,1,3,0)
 ;;=3^Inflammatory Liver Disease,Oth Spec
 ;;^UTILITY(U,$J,358.3,16952,1,4,0)
 ;;=4^K75.89
 ;;^UTILITY(U,$J,358.3,16952,2)
 ;;=^5008829
 ;;^UTILITY(U,$J,358.3,16953,0)
 ;;=K76.4^^61^778^23
